A significant discovery in cancer investigation is occurring with the use of mini-antibodies to reactivate damaged p53. This crucial cancer inhibitor protein is frequently inactivated in several types of malignancies, https://bookmarkedblog.com/story907178/vhh-fragments-reactivate-p53-the-promising-pathway-for-tumor-management